| Product Code: ETC7657845 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continues to rely on a diverse range of countries for importing oral antivirals, with Switzerland, UK, Belgium, USA, and Germany leading the way. The low Herfindahl-Hirschman Index (HHI) indicates a competitive market with no dominant players. Despite a negative Compound Annual Growth Rate (CAGR) from 2020 to 2024, the marginal decline in growth rate from 2023 to 2024 suggests a relatively stable market for oral antiviral imports in Israel. Monitoring trends and factors influencing these statistics can provide valuable insights for stakeholders in the pharmaceutical industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Oral Antiviral Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Oral Antiviral Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Oral Antiviral Market - Industry Life Cycle |
3.4 Israel Oral Antiviral Market - Porter's Five Forces |
3.5 Israel Oral Antiviral Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Israel Oral Antiviral Market Revenues & Volume Share, By Drug class, 2022 & 2032F |
3.7 Israel Oral Antiviral Market Revenues & Volume Share, By Distribution channel, 2022 & 2032F |
4 Israel Oral Antiviral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of viral infections in Israel |
4.2.2 Growing awareness about the benefits of oral antiviral medications |
4.2.3 Technological advancements in oral antiviral drug development |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for oral antiviral drugs |
4.3.2 High costs associated with research and development of oral antiviral medications |
5 Israel Oral Antiviral Market Trends |
6 Israel Oral Antiviral Market, By Types |
6.1 Israel Oral Antiviral Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Oral Antiviral Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Israel Oral Antiviral Market Revenues & Volume, By Hepatitis, 2022 - 2032F |
6.1.4 Israel Oral Antiviral Market Revenues & Volume, By Human Immunodeficiency Virus (HIV), 2022 - 2032F |
6.1.5 Israel Oral Antiviral Market Revenues & Volume, By Influenza, 2022 - 2032F |
6.1.6 Israel Oral Antiviral Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 Israel Oral Antiviral Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Israel Oral Antiviral Market Revenues & Volume, By Protease inhibitors, 2022 - 2032F |
6.2.3 Israel Oral Antiviral Market Revenues & Volume, By Reverse transcriptase inhibitors, 2022 - 2032F |
6.2.4 Israel Oral Antiviral Market Revenues & Volume, By Others, 2022 - 2032F |
6.3 Israel Oral Antiviral Market, By Distribution channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Oral Antiviral Market Revenues & Volume, By Hospital pharmacies, 2022 - 2032F |
6.3.3 Israel Oral Antiviral Market Revenues & Volume, By Drug store and retail pharmacies, 2022 - 2032F |
6.3.4 Israel Oral Antiviral Market Revenues & Volume, By Online providers, 2022 - 2032F |
7 Israel Oral Antiviral Market Import-Export Trade Statistics |
7.1 Israel Oral Antiviral Market Export to Major Countries |
7.2 Israel Oral Antiviral Market Imports from Major Countries |
8 Israel Oral Antiviral Market Key Performance Indicators |
8.1 Number of clinical trials conducted for oral antiviral drugs in Israel |
8.2 Adoption rate of oral antiviral medications by healthcare providers in Israel |
8.3 Patient adherence rates to oral antiviral treatment regimens |
9 Israel Oral Antiviral Market - Opportunity Assessment |
9.1 Israel Oral Antiviral Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Israel Oral Antiviral Market Opportunity Assessment, By Drug class, 2022 & 2032F |
9.3 Israel Oral Antiviral Market Opportunity Assessment, By Distribution channel, 2022 & 2032F |
10 Israel Oral Antiviral Market - Competitive Landscape |
10.1 Israel Oral Antiviral Market Revenue Share, By Companies, 2025 |
10.2 Israel Oral Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here